Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment

Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment

Emergency use authorization of drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by regulatory authorities has provided new options to treat high-risk outpatients with mild-to-moderate Coronavirus disease 2019 (COVID-19). We conducted an ambispective cohort study of patients...

Full description

Bibliographic Details
Main Authors: Angioletta Lasagna, Irene Cassaniti, Daniele Lilleri, Mattia Quaccini, Alessandra Ferrari, Paolo Sacchi, Raffaele Bruno, Fausto Baldanti, Paolo Pedrazzoli
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
remdesivir
nirmatrelvir/ritonavir
real-life data
COVID-19
vaccine
cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1036473/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.1036473/full

Similar Items